Search Results
Found 3 results
510(k) Data Aggregation
(138 days)
Biomet Comprehensive Reverse Shoulder products are indicated for use in patients whose shoulder joint has a grossly deficient rotator cuff with severe arthropathy and/or previously failed shoulder joint replacement with a grossly deficient rotator cuff. The patient must be anatomically and structurally suited to receive the implants and a functional deltoid muscle is necessary.
The Comprehensive Reverse Shoulder is indicated for primary, fracture, or revision total shoulder replacement for the relief of pain and significant disability due to gross rotator cuff deficiency.
Titanium glenospheres are intended for patients with Cobalt Alloy material sensitivity. The wear of these devices has not been tested but, based on pin on disk testing, the wear rate is inferior to that of cobalt alloy glenospheres. A Cobalt Alloy glenosphere is the recommended component for reverse shoulder arthroplasty patients without material sensitivity to cobalt alloy.
Glenoid components with Hydroxyapatite (HA) coating applied over the porous coating are indicated only for uncemented biological fixation applications. The Glenoid Baseplate components are intended for cementless application with the addition of screw fixation.
Interlok finish humeral stems are intended for cemented use and the MacroBond coated humeral stems are intended for press-fit or cemented applications. Humeral components with porous coated surface coating are indicated for either cemented or uncemented biological fixation applications.
This submission is for manufacturing of an alternate version of exiting Comprehensive Standard and Mini Baseplates components with the porous plasma spray (PPS) coating applied by an outside vendor and the addition of Zimmer's Calcicoat coating. There is no change to the design to these existing products.
The new Comprehensive Reverse Augmented Baseplate has an augmented backside while retaining the existing Comprehensive Reverse baseplate geometry. The device will be available with three augment sizes, Small, Medium and Large. The new variant will be manufactured with PPS coating applied by a vendor and Zimmer Calcicoat coating.
This document is a 510(k) Summary for the Zimmer Biomet Comprehensive Augmented Glenoid Components, Comprehensive Standard Baseplate, and Comprehensive Mini Baseplate. It describes the acceptance criteria and the study that proves the device meets the acceptance criteria in the context of a medical device submission for substantial equivalence to predicates, not an AI/ML device. Therefore, the questions related to AI/ML specific criteria (such as sample size for test/training sets, expert ground truth, MRMC studies, standalone performance, etc.) are not applicable to the information provided in this document.
The acceptance criteria and device performance are described in terms of engineering and material characteristics for orthopedic implants.
1. Table of Acceptance Criteria and Reported Device Performance
The document summarizes the non-clinical tests performed to demonstrate substantial equivalence. These are not performance metrics in the sense of accuracy, sensitivity, or specificity as would be the case for AI/ML models, but rather engineering and material properties.
| Acceptance Criteria (Non-Clinical Tests) | Reported Device Performance (Summary) |
|---|---|
| PPS and HA/TCP Coating Pore Size and Porosity | Not explicitly detailed, but implied to be compliant with acceptance criteria as part of the overall "Substantial Equivalence Conclusion" |
| Glenoid Loosening/Disassociation Test Method | Not explicitly detailed, but implied to be compliant. |
| Shear Testing Justification | Justified |
2. Sample Size Used for the Test Set and the Data Provenance
This is an orthopedic implant 510(k) submission, not a study of an AI/ML device. Therefore, the concept of a "test set" in the machine learning sense, or data provenance in terms of patient data origin and retrospectivity/prospectivity, is not applicable. The documentation refers to mechanical and material testing, which would have specific sample sizes for engineering tests (e.g., number of specimens tested for shear strength, porosity), but these details are not provided in this summary document.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and the Qualifications of Those Experts
Not applicable. This is not an AI/ML device that requires human expert review for establishing ground truth on image data or similar. The "ground truth" here refers to established engineering standards and material specifications.
4. Adjudication Method for the Test Set
Not applicable. Ground truth establishment for AI/ML model test sets.
5. If a Multi Reader Multi Case (MRMC) comparative effectiveness study was done
Not applicable. This is not an AI/ML device where human readers interact with AI assistance.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done
Not applicable. This is an orthopedic implant, not an algorithm.
7. The Type of Ground Truth Used
The "ground truth" in this context refers to:
- Engineering Standards and Material Specifications: The device's performance against established industry standards for orthopedic implants, including mechanical strength, durability, material composition (e.g., PPS and HA/TCP coating properties), and resistance to loosening/disassociation.
- Predicate Device Performance: The comparison of the proposed device's characteristics to those of legally marketed predicate devices, demonstrating that any differences "do not raise new questions of safety and effectiveness."
8. The Sample Size for the Training Set
Not applicable. This is not an AI/ML device.
9. How the Ground Truth for the Training Set Was Established
Not applicable. This is not an AI/ML device.
Summary of Device and Performance Aspects from the Document:
- Device Name: Comprehensive Augmented Glenoid Components, Comprehensive Standard Baseplate, Comprehensive Mini Baseplate
- Purpose: Manufacturing of alternate versions of existing Comprehensive Standard and Mini Baseplates with a different porous plasma spray (PPS) coating vendor and the addition of Zimmer's Calcicoat coating. Also includes a new Comprehensive Reverse Augmented Baseplate with an augmented backside.
- Basis for Substantial Equivalence:
- Intended Use & Indications for Use: Identical to predicate devices.
- Materials: Substrate and porous coating are the same as the predicate; Calcicoat® coating has been previously cleared.
- Design Features: Identical or similar to predicates.
- Sterilization: Identical assurance level and validation methods to predicate (new vendor).
- Performance Data Provided: Non-clinical tests were conducted. These included assessments of PPS and HA/TCP Coating Pore Size and Porosity, Glenoid Loosening/Disassociation Test Method, and Shear testing justification. No clinical tests were provided.
- Conclusion: The proposed devices are deemed substantially equivalent because they have the same intended use and indications for use, similar technological characteristics, and the differences do not raise new questions of safety and effectiveness, meaning they are at least as safe and effective as the legally marketed predicate devices.
Ask a specific question about this device
(235 days)
Biomet Comprehensive Vault Reconstruction System is indicated for use in patients whose shoulder joint has a grossly deficient rotator cuff with severe arthropathy and/or previously failed shoulder joint replacement with a grossly deficient rotator cuff. The patient must be anatomically suited to receive the implants and a functional deltoid muscle is necessary.
The Comprehensive Vault Reconstruction System is indicated for primary, fracture, or revision total shoulder replacement for the relief of pain and significant disability due to gross rotator cuff deficiency.
The Comprehensive Vault Reconstruction System glenoid baseplate components are intended for cementless application with the addition of screw fixation in patients with unusual anatomy and/or extensive bone loss which precludes the use of a standard glenoid baseplate component.
Titanium glenospheres are intents with Cobalt Alloy material sensitivity. The wear of these devices has not been tested but, based on pin on disk testing, the wear rate is inferior to that of cobalt alloy glenospheres. A Cobalt Alloy glenosphere is the recommended component for reverse shoulder arthroplasty patients without material sensitivity to cobalt alloy.
Interlok finish humeral stems are intented use and the MacroBond coated humeral stems are intended for press-fit or cemented applications. Humeral components with porous coated surface coating are indicated for either cemented or uncemented biological fixation applications.
The Comprehensive Vault Reconstruction System (VRS) is a glenoid baseplate for reverse shoulder arthroplasty designed to match the anatomy of an individual patient.
The provided text describes the regulatory clearance (K152754) for the Biomet Comprehensive Vault Reconstruction System (VRS). However, it does not include detailed acceptance criteria or a study proving performance against such criteria. The document is a 510(k) summary, which focuses on demonstrating substantial equivalence to a legally marketed predicate device rather than presenting new clinical performance data with specific acceptance criteria.
Key takeaway: The document explicitly states, "No clinical data submitted" and "No clinical data was necessary for a determination of substantial equivalence." Therefore, it does not contain the information requested regarding acceptance criteria and performance studies.
Despite the absence of the requested information, here's a breakdown of what can be inferred or directly stated from the provided text, addressing the points where possible:
1. Table of Acceptance Criteria and Reported Device Performance:
The document does not provide a table of acceptance criteria or specific quantitative performance metrics comparing the device to such criteria. The performance data section only lists the types of non-clinical tests conducted.
| Acceptance Criteria | Reported Device Performance |
|---|---|
| Not specified in the document | Not specified quantitatively against criteria in the document |
| Non-clinical tests performed: | |
| Compressed Shear Load to Failure Testing | "performed within the intended use" |
| Baseplate Fixation Testing | "performed within the intended use" |
| Axial Separation Testing | "performed within the intended use" |
| Torsional Separation Testing | "performed within the intended use" |
| Software Validation | "performed within the intended use" |
| Cadaver Validation | "performed within the intended use" |
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective):
- Sample Size: Not specified for any of the listed non-clinical tests.
- Data Provenance: Not specified. The tests are non-clinical (mechanical, software, cadaveric), so country of origin for patient data is irrelevant. Whether the tests were retrospective or prospective is not mentioned, but for mechanical and cadaveric testing, this distinction is less common than for clinical studies.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience):
This information is not applicable as the submission is for a medical device (a shoulder prosthesis) and relies on non-clinical testing for substantial equivalence, not expert-adjudicated clinical data to establish ground truth in the context of image interpretation or diagnosis.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:
Not applicable. As noted above, this submission focuses on non-clinical testing for a device, not on diagnostic performance where expert adjudication for ground truth would be required.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
Not applicable. This device is a shoulder prosthesis, not an AI-powered diagnostic tool. No MRMC study was performed or required for this type of submission.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
Not applicable. This device is a physical shoulder implant, not an algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc):
For the non-clinical tests, the "ground truth" would be established by engineering standards and validated physical measurements or simulations, rather than clinical consensus or pathology. For example:
- Compressed Shear Load to Failure Testing: Ground truth would be the mechanical properties of the materials and design under load, validated by destructive testing.
- Software Validation: Ground truth would be the specified functional requirements and expected outputs of the software, validated through testing.
- Cadaver Validation: Ground truth would relate to the anatomical fit, surgical procedure, and stability of the implant within a cadaveric model, evaluated by anatomists or orthopedic surgeons.
8. The sample size for the training set:
Not applicable. This is a physical medical device. There is no "training set" in the context of machine learning or AI.
9. How the ground truth for the training set was established:
Not applicable, as there is no training set for a physical medical device.
Ask a specific question about this device
(151 days)
The Comprehensive® Reverse Shoulder is indicated for use in patients whose shoulder joint has a grossly deficient rotator cuff with severe arthropathy and/or previously failed shoulder joint replacement with a grossly deficient rotator cuff. The patient must be anatomically and structurally suited to receive the implants and a functional deltoid muscle is necessary.
The Comprehensive® Reverse Shoulder is indicated for primary, fracture, or revision total shoulder replacement for the relief of pain and significant disability due to gross rotator cuff deficiency.
Titanium olenospheres are intended for patients with colbalt alloy material sensitivity. The wear of these devices has not been tested but, based on pin on disk testing, the wear rate is inferior to that of cobalt alloy glenospheres. A cobalt alloy glenosphere is the recommended component for reverse shoulder arthroplasty patients without material sensitivity to cobalt alloy.
Glenoid components with Hydroxyapatite (HA) coating applied over the porous coating are indicated only for uncemented biological fixation applications. The Glenoid Baseplate components are intended for cementless application with the addition of screw fixation.
Interlok® finish humeral stems are intended for cemented use and the Macro Bond® coated humeral stems are intended for press-fit or cemented applications. Humeral components with porous coated surface coating are indicated for either cemented or uncemented biological fixation applications.
The device is a single-use implant.
The Titanium Alloy Glenosphere Prosthesis consists of a series of various sized modular glenospheres with variable offset between 0.5mm and 4.5 mm. Titanium alloy material has been selected to provide the surgeon with an alternate material to treat patients with nickel allergies. Each modular glenosphere consists of a "head" and a taper adaptor. The taper adaptor is impacted into the head in a certain position to achieve the desired amount of offset. The system can be used with Biomet's Comprehensive® Reverse Shoulder System or Biomet's BioModular® Reverse Shoulder System.
This document is a 510(k) premarket notification for a medical device, specifically the Comprehensive® Reverse Shoulder - Titanium Glenosphere. It focuses on demonstrating substantial equivalence to previously marketed devices rather than presenting a study proving that the device meets specific acceptance criteria based on performance data.
Therefore, many of the requested sections about acceptance criteria, detailed study design, and performance metrics (like sample size for test sets, expert ground truth, effect size, etc.) are not applicable or not provided in this type of regulatory submission. The document explicitly states "No clinical data submitted" and "No clinical data was necessary for a determination of substantial equivalence."
However, I can extract the relevant information that is present:
1. A table of acceptance criteria and the reported device performance
Since this is a substantial equivalence submission, the "acceptance criteria" are implicitly defined by the characteristics and performance of the predicate devices. The performance reported here is primarily related to non-clinical bench testing.
| Acceptance Criteria (Implicit for Substantial Equivalence) | Reported Device Performance (Non-Clinical) |
|---|---|
| Functional equivalence to predicate devices | "The number of components, sizing, and all dimensions are identical to the predicate." "The results of testing indicate the devices performed within the intended use, did not raise any new safety and efficacy issues and were found to be substantially equivalent to the predicate devices." |
| Material compatibility/performance | "Titanium alloy material has been selected to provide the surgeon with an alternate material to treat patients with nickel allergies." (Implied acceptance for patients with cobalt alloy material sensitivity). |
| Mechanical integrity (e.g., taper locking) | Test Conducted: Torsional separation of tapers. (The document states this test was performed, implying the device met internal acceptance criteria for taper integrity, though specific values are not provided in this summary.) |
| Wear characteristics | "The wear of these devices has not been tested but, based on pin on disk testing, the wear rate is inferior to that of cobalt alloy glenospheres. A cobalt alloy glenosphere is the recommended component for reverse shoulder arthroplasty patients without material sensitivity to cobalt alloy." (This is a caveat rather than a direct performance claim, acknowledging inferior wear for the titanium compared to cobalt, but still implying acceptance for its specific indication in material-sensitive patients.) |
Detailed Study Information (Not applicable/Not provided in this document type):
As noted, this document is a 510(k) summary demonstrating substantial equivalence, not a clinical study report with detailed performance data against specific acceptance criteria. Therefore, the following information is not present:
- Sample sizes used for the test set and the data provenance: Not provided for this type of submission which relies on non-clinical testing for substantial equivalence. No clinical test set.
- Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable, as there was no clinical test set requiring expert ground truth for this submission.
- Adjudication method for the test set: Not applicable, as there was no clinical test set.
- If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This device is an orthopedic implant, not an AI diagnostic tool.
- If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable. This device is an orthopedic implant, not a standalone algorithm.
- The type of ground truth used (expert consensus, pathology, outcomes data, etc.): Not applicable. "No clinical data submitted." For non-clinical tests (like torsional separation), the "ground truth" would be engineering specifications and predicate device performance.
- The sample size for the training set: Not applicable. This device is an orthopedic implant, not an AI/algorithm that requires a training set.
- How the ground truth for the training set was established: Not applicable.
Ask a specific question about this device
Page 1 of 1